BIOLASE, Inc.

	BIOLASE, Inc., the global leader in dental lasers, announced a joint product promotion with Hu-Friedy, the global leader in the manufacturing of dental instruments, at the 2019 Chicago Midwinter Meeting. BIOLASE's Waterlase products and Hu-Friedy's AIRFLOW therapy devices and Piezon power scaling devices are complementary in delivering positive periodontal and implant maintenance outcomes.

The two companies will feature a cross-promotion that offers exclusive deals and product samples for complementary product lines at the Chicago Dental Society Midwinter Meeting Feb. 21-23. Attendees will be treated to an exclusive opportunity when visiting the BIOLASE booth; dentists who purchase a BIOLASE Waterlase All-Tissue Laser will receive a Hu-Friedy EMS Piezon 150 at no additional cost. Additionally, dentists who visit the BIOLASE booth for a demonstration of the Waterlase laser and the Hu-Friedy booth for a demonstration of the AIR-FLOW Master Piezon will receive a Hu-Friedy Orban Knife at no charge*

Read more: What Waterlase can bring to your dental practice

	"We're proud to partner with a company that shares our goal in addressing soft tissue management at the earliest stages," says BIOLASE CEO Todd Norbe. "By doing so, we can help avoid future tissue and bone loss, while focusing on the growing concern around peri-implantitis."

	Customers can visit the BIOLASE booth and the Hu-Friedy booth at the event for more information.

*While supplies last. Certain restrictions apply. Visit the BIOLASE or Hu-Friedy booths for details.

Articles

The two companies will partner to feature a cross-promotion that offers exclusive deals and product samples.

BIOLASE, Hu-Friedy announce joint product promotion at Chicago Midwinter

	BIOLASE, Inc. announced today it will be previewing Epic Pro™, an all-new dental diode laser system at the upcoming Greater New York Dental Meeting.

	The Epic Pro reportedly offers the most laser power of any diode laser in dentistry. The newest addition to the Epic family of dental soft-tissue lasers, Epic Pro features several new innovations that are said to be industry-firsts:

			A new super pulse technology for more precise, enhanced laser tissue cutting

			Real-time automatic power control to enhance speed and consistency when performing surgery

			Pre-initiated, bendable, disposable tips with new smart tip technology to ensure tip performance and quality

	The new systems will reportedly provide even more predictable, minimally-invasive solutions for soft-tissue management than is currently offered by its market-leading Epic X product and other diode lasers on the market. It represents the first premium grade diode laser from BIOLASE.

Watch: Dr. Michael Miyasaki explains the benefits of soft-tissue lasers for dentists, hygienists

	The Epic Pro laser system is currently undergoing premarket notification review by FDA for dental/surgical operations, intended for use in contact and non-contact techniques for incision, excision, vaporization, ablation, hemostasis, or coagulation of intraoral and extra-oral soft tissue (including marginal and interdental gingiva and epithelial lining of free gingiva). It is not yet available for sale within the United States.

	To learn more, call 888-424-6527 or visit 

. You can also visit the BIOLASE booth #422 at the 

 to preview this latest breakthrough in soft-tissue laser technology.

BIOLASE announces the Epic Pro™ dental diode laser system.

BIOLASE announces the Epic Pro™ dental diode laser system

	BIOLASE, Inc., a global leader in dental lasers, announced it recently entered into a development and distribution agreement with IPG Photonics Corporation’s medical laser division, IPG Medical.

 is said to have pioneered the development and commercialization of optical fiber-based lasers, reportedly creating a new generation of lasers with superior performance, reliability and lower costs. IPG grew to become one of the world’s largest laser companies, opening up a myriad of industrial, manufacturing and medical applications using its fiber and semiconductor lasers.

Related reading: BIOLASE Epic X diode laser is a complete solution for the whole dental team

	The development and distribution agreement between 

 and IPG covers several projects in various stages of development with the expectation that these projects will culminate in commercialized joint dental laser products, accessories or integral system components. The parties will collaborate in the design and development of these new products and applications with each party contributing their respective technological expertise, know-how and development resources.

	BIOLASE will be responsible for U.S. and international registrations of all dental products resulting from the agreement and will have exclusive worldwide commercial distribution rights for certain products over a multi-year initial term after completion of development.

	“We are extremely fortunate to partner with IPG, the world leader in fiber laser technology,” said 

Harold C. Flynn, Jr., president and CEO of BIOLASE

. “This partnership brings with it significant opportunity to advance our product designs and our supply chain, ultimately to provide a broader, deeper and more capable portfolio of laser-based solutions to dental practitioners globally.

	“This will advance efforts to fulfill our purpose, enabling clinicians to repair and restore patient’s dental conditions, while alleviating pain, and reducing the anxiety commonly associated with invasive dental procedures."

	“This partnership with BIOLASE fits very well with IPG’s strategic development and desire to build our medical application business," said Dr. Gregory Altshuler, president of IPG Medical. "The parties will combine their expertise and capabilities to improve existing and develop new dental laser applications in markets with significant unmet clinical needs. BIOLASE’s established dental channels deepen our distribution capabilities in this area and leverage our patented dental laser technology and platforms.”

Related reading: BIOLASE launches first-ever practice growth guarantee

BIOLASE, Inc., a global leader in dental lasers, announced it recently entered into a development and distribution agreement with IPG Photonics Corporation’s medical laser division, IPG Medical.

BIOLASE enters into development agreement with IPG Photonics

	BIOLASE, Inc., a global leader in dental lasers, announced an upgrade of WaterLase iPlus

 2.0 dental laser to provide dental practitioners a clinical protocol and application to assist in the effective management of peri-implantitis.

	Said to be a growing problem in dentistry, 

 is a destructive inflammatory process affecting the soft and hard tissues surrounding dental implants.

 for periodontitis in 2014 and reportedly has now leveraged that significant clinical accomplishment to develop 

 protocol to assist in the management of peri-implantitis. Both of these peridontal clinical protocols are now integrated into 

. WaterLase is said to use proprietary and patented 

, which emit a corona of laser energy to manage infection, necrosed tissue, anaerobes and other material compromising the implant surface and surrounding periodontal structures.

Related reading: BIOLASE introduces first-ever practice growth guarantee with launch of WaterLase iPlus 2.0

	"Peri-implantitis is a growing problem in implant dentistry," said 

BIOLASE President and CEO Harold C. Flynn, Jr.

 "BIOLASE is committed to providing dental professionals with clinically advanced technology to address today's dental health challenges. The REPAIR implant protocol is an important new WaterLase capablity, and we're excited to bring it to practitioners and their patients. The clinically important new addition to WaterLase is part of our continued committment to provide better care for patients and provide a foundation for practice growth."

	With a reported increase in the number of dental implants placed around the world, incidences of peri-implantitis are a growing health issue that is frequently encountered in the dental practice. Estimates for the incidence of peri-implantitis vary between 10 and 43 percent of all dental implants placed. WaterLase technology is designed to offer a minimally invasive alternative to traditional treatment of peri-implantitis.

More from BIOLASE: Unveiling the BIOLASE Epic X diode laser

 protocol, the WaterLase iPlus 2.0 now provides preprogrammed settings and step-by-step applications for more than 50 procedures and clinical indications.

	Advantages of the new WaterLase iPlus 2.0 

	- Minimally invasive protocol to assist in the management of perimucositis and peri-implantitis

	- Easy access and not harmful to implant surface

	- Closed-flat protocol can be used for early peri-implantitis

	- Treat site-specific or whole-mouth cases

	- Laser photoacoustic properties effectively debride the implant surface

	- Supported by more than 40 examples of clinical evidence

	To learn more about WaterLase iPlus 2.0 and the new 

. For those heading  to the ADA in Washington D.C. this week, BIOLASE invites you to come by and see the newly upgraded WaterLase (Booth #2637).

BIOLASE, Inc., a global leader in dental lasers, announced an upgrade of WaterLase iPlus® 2.0 dental laser to provide dental practitioners a clinical protocol and application to assist in the effective management of peri-implantitis.